Early Target Attainment With Continuous Infusion Meropenem and Piperacillin/Tazobactam and Utilization of Therapeutic Drug Monitoring in Critically Ill Patients: A Retrospective Cohort Study From 2017 to 2020.

Sarah Dräger,Matthias von Rotz,Niklaus D Labhardt,Martin Siegemund,Katharina M Rentsch,Michael Osthoff,Fabian C Franzeck

Open forum infectious diseases（2023）

引用 0|浏览12

暂无评分

摘要

Continuous infusion meropenem and piperacillin/tazobactam yielded excellent and moderate early pharmacological target attainment in critically ill patients, respectively. The TDM was mainly used to decrease meropenem dosage.

查看译文

关键词

continuous infusion,critically ill patients,meropenem,therapeutic drug monitoring

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要